Skip to main content
Signal8

Regen BioPharma Inc (RGBP)

Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Regen BioPharma, Inc. logo

Regen BioPharma, Inc.

OTC:RGBPHealthcare
$0.0001
Mkt Cap$218K
Float1.58B
O/S1.68B
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$237K
Net Income-$1.27M
Total Assets$275K
Free Cash Flow-$384K
Debt & Equity
Total Debt$794K
Total Equity-$6.28M
Preferred Stock$1K
Shares Outstanding
Short Interest
Split History4 splits · 1 reverse
  1. 2:1Forward split
    Feb 10, 20261 share → 2
  2. 2:1Forward split
    Nov 4, 20241 share → 2
  3. 3:1Forward split
    Jul 5, 20241 share → 3
  4. 1:1,500Reverse split
    Mar 6, 20231,500 shares → 1
Balance Sheet Details
Assets$275K
Liabilities$6.56M
Accounts Receivable$205K
Accounts Payable$30K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-30
Revenue$237K$237K$237K$236K$171K$110K$110K$100K$110K$100K$192K$0$0$0
YoY Growth0.0%0.0%0.4%37.6%55.6%0.0%10.0%-9.1%10.0%-47.9%----
Cost of Revenue$0$77K$0$0$0$0$0$0$0$0$0$0$0$0
Gross Profit$237K$237K$237K$186K$146K$110K$110K$100K$110K$100K$192K$0$0$0
Gross Margin100.0%100.0%100.0%78.8%85.4%100.0%100.0%100.0%100.0%100.0%100.0%---
Research and Development$12K$154K$212K$275K$37K$13K$46K$374K$1.15M$671K$282K$24K$8K$43K
Selling, General, and Administrative$473K$500K$711K$300K$335K$306K$821K$1.15M$1.47M$2.39M$1.89M$682K$311K$359K
Other$90K$0$0$0$0$0$2K$0$0$0$0$0$0$0
Total Operating Expenses$575K$654K$924K$575K$347K$319K$867K$1.53M$2.62M$3.06M$2.17M$706K$320K$401K
Operating Income (EBIT)-$339K-$417K-$687K-$340K-$201K-$209K-$757K-$1.43M-$2.51M-$2.96M-$1.98M-$706K-$320K-$401K
Operating Margin-143.1%-176.3%-290.4%-144.4%-117.4%-190.0%-688.2%-1426.0%-2282.7%-2957.0%-1030.7%---
Interest Expense$210K$247K$309K$255K$367K$943K$1.7M$1.56M$576K$46K$22K$2K$0$0
Interest Income$0$0$0$455$230$0$1K$10K$2K$1K$1K$233$0$0
Other Income (Expense)-$936K-$251K$1.84M$2.78M-$6.56M$3.62M-$1.87M-$3.29M-$3.33M-$457K-$231K-$50K-$35K$0
Income Before Tax (EBT)-$1.27M-$668K$1.16M$2.44M-$6.76M$3.41M-$2.62M-$4.71M-$5.84M-$3.41M-$2.21M-$756K-$355K-$401K
Income Tax Expense$0$0$0$0$0$0$0$0$0$0$21K$2K$0$0
Net Income-$1.27M-$668K$1.02M$2.23M-$6.76M$2.73M-$2.62M-$4.71M-$5.84M-$3.41M-$2.21M-$756K-$355K-$401K
Net Income Margin-538.8%-282.4%432.9%945.6%-3951.7%2483.6%-2384.5%-4715.0%-5308.2%-3414.0%-1151.6%---
Supplementary Data
EPS-0.05-0.160.140.36-1.691.90-1.95-46.50-61.93-40.05-190.43-21.93-28.100.00
Diluted EPS-0.05-0.160.140.36-1.691.90-1.95-46.50-61.93-40.05-190.43-21.93-28.100.00
Weighted Average OS23.52M4.11M7.07M3.14M2.01M939,8971.38M101,39494,28485,22658,79068,97512,6330
EBITDA-$1.01M-$418K$1.22M$2.77M-$6.35M$4.97M$486K-$1.85M-$4.79M-$3.35M-$210K-$48K-$35K$234K
EBITDA Margin-427.8%-176.7%514.4%1176.2%-3707.5%4515.0%441.9%-1847.7%-4350.7%-3348.4%-109.2%---
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-30
Assets
Current Assets
Cash and Cash Equivalents$716$716$121K$51K$727K$0$8K$8K$270K$25K$39K$0$116K$923
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$716$716$121K$51K$727K$0$8K$8K$270K$25K$39K$0$116K$923
Accounts Receivable$205K$95K$0$254K$219K$103K$71K$12K$174K$113K$13K$0$0$0
Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$69K$0$0$0$0$0$0$0$0$0$0$11K$0$0
Total Current Assets$275K$160K$131K$336K$994K$103K$79K$43K$478K$207K$62K$11K$116K$923
Long-Term Assets
Property, Plant & Equipment Net$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$18K$18K$223K$223K$218K$20K$20K$166K$466K$112K$158K$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0-$223K-$218K-$20K-$20K$0$0$0$0$0$0$0
Total Long-Term Assets$18K$18K$223K$223K$218K$20K$20K$166K$466K$112K$158K$0$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$275K$178K$354K$559K$1.21M$123K$99K$209K$944K$319K$220K$11K$116K$923
Liabilities
Current Liabilities
Accounts Payable$30K$30K$30K$29K$91K$110K$92K$81K$496K$241K$26K$3K$0$0
Short-Term Debt$794K$815K$607K$1.27M$3.58M$2.6M$2.14M$775K$360K$152K$223K$126K$0$0
Current Income Tax Payable$0$0$4K$4K$4K$4K$4K$4K$857$33K$2K$0$0$0
Current Unearned Revenue$1.34M$1.47M$1.61M$1.72M$1.84M$2.11M$1.57M$68K$773K$33K$2K$0$0$0
Other Current Liabilities$5.73M$1.81M$1.4M$3.55M$6.89M$2.65M$7.8M$6.74M$4.25M$142K$33K$8K$0$0
Total Current Liabilities$6.56M$5.37M$5.31M$8.6M$14.7M$7.46M$11K$8.67M$5.86M$799K$318K$140K$0$0
Long-Term Liabilities
Long-Term Debt$0$0$150K$0$0$0$5K$657K$332K$107K$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$0$0$150K$3.02M$0$0$5K$657K$332K$107K$0$0$0$0
Other Liabilities$0$0$0-$3.02M$0$0$0$0$0$0$0$0$0$0
Total Liabilities$6.56M$5.37M$5.46M$8.6M$14.7M$7.46M$11.01M$9.33M$6.2M$906K$318K$140K$0$0
Stockholders' Equity
Preferred Stock$1K$1K$45$48K$48K$43K$39K$18K$17K$14K$6K$0$0$0
Common Stock$4K$527$352$503K$435K$160K$60K$18K$14K$14K$11K$5K$5K$10
Retained Earnings-$21.69M-$20.62M-$19.75M-$20.91M-$23.35M-$16.58M-$20M-$17.46M-$12.74M-$20.22M-$12.47M-$1.28M-$522K-$167K
Comprehensive Income & Other-$223K$736K$736K$0$0$0$0$53K$88K-$80K-$34K$0$0$0
Other Stockholders' Equity$15.41M$15.42M$14.64M$12.37M$9.43M$9.09M$9.03M$8.32M$7.48M$19.62M$12.37M$1.14M$633K$168K
Total Equity-$6.28M-$5.19M-$5.1M-$8.04M-$13.49M-$7.33M-$10.91M-$9.12M-$5.25M-$587K-$97K-$130K$116K$923
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$275K$178K$354K$559K$1.21M$123K$99K$209K$944K$319K$220K$11K$116K$923
Supplementary Data
Total Debt$794K$815K$756K$1.27M$3.58M$2.6M$2.15M$1.43M$693K$260K$223K$126K$0$0
Net Debt$793K$814K$635K$1.22M$2.86M$2.6M$2.14M$1.42M$423K$235K$184K$126K-$116K-$923
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-30
Operating Activities
Net Income-$1.27M-$867K$1.16M$2.44M-$6.77M$3.41M-$2.62M-$4.72M-$5.84M-$7.75M-$11.2M-$756K-$355K-$401K
Depreciation & Amortization$52K$29K$864$71K$51K$610K$1.41M$1.3M$477K$19K$1.98M$706K$320K$401K
Deferred Income Tax$0$0-$255K-$46K-$51K-$4K-$1.41M$0-$477K-$19K$0$0$0$0
Stock-Based Compensation$0$6K$348K$46K$0$4K$55K$151K$3K$3K$309K$0$70K$0
Changes in Working Capital:
  Accounts Receivable-$110K-$95K$254K-$41K-$110K-$34K-$71K$30K$83K-$83K$0$0$0$0
  Inventory$0$0$0$0$4.58M-$4M$620K$0$3.25M$803K$0$0$0$0
  Accounts Payable$821-$5$875-$63K-$19K$18K$11K-$415K$255K$215K$23K$3K$0$0
  Other Working Capital$144K-$160K-$2.18M-$3.03M-$2K$3K$79K$1.69M-$186K-$592K$39K$6K$0$0
Total Working Capital Change$35K-$254K-$1.93M-$3.14M$4.45M-$4.01M$640K$1.28M$3.4M$343K$62K$9K$116K$0
Other Non-Cash Items$804K$139K$504K$16K$1.18M$4K$1.45M$404K$544K$5.73M-$2.17M-$706K-$436K-$401K
Net Cash from Operating-$384K-$693K-$174K-$607K-$1.13M$19K-$482K-$1.58M-$1.89M-$1.67M-$11.01M-$747K-$285K-$401K
Investing Activities
Capital Expenditures$0$0-$3$0$0$0$0$0$0$0$0$0$0$0
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$25K$495K$0$50K$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$25K$495K$0$50K-$6K$0$0$0$0$0$0
Net Cash from Investing$0$0$0$25K$495K$0$50K-$6K$0$0$0$0$0$0
Financing Activities
Debt Repaid---$95K---$343K-$1.38M-$1.62M-$300K-$973K---
Common Stock Issuance$58K$146K$250K$46K$159$3K$6K$25K$293K$626K$103K$511K$400K$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$50K$573K$244K$499$1.36M-$1K$0-$111K$521K$1.3M$9.96M$120K$0$403K
Net Cash from Financing$452K$573K$244K-$94K$1.36M-$27K$432K$1.32M$2.14M$1.66M$11.05M$631K$400K$403K
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash$69K-$120K$70K-$676K$727K-$8K-$164-$262K$245K-$14K$39K$0$115K$2K
Supplementary Data
Operating Cash Flow-$384K-$693K-$174K-$607K-$1.13M$19K-$482K-$1.58M-$1.89M-$1.67M-$11.01M-$747K-$285K-$401K
Capital Expenditure$0$0-$3$0$0$0$0$0$0$0$0$0$0$0
Free Cash Flow-$384K-$693K-$174K-$607K-$1.13M$19K-$482K-$1.58M-$1.89M-$1.67M-$11.01M-$747K-$285K-$401K
Cash at Beginning$716$121K$51K$727K$0$8K$8K$270K$25K$39K$0$116K$923$0
Cash at End$70K$715$121K$51K$727K$0$8K$8K$270K$25K$39K$116K$116K$2K